Colin G. Miller

1.5k total citations
38 papers, 1.1k citations indexed

About

Colin G. Miller is a scholar working on Rheumatology, Surgery and Orthopedics and Sports Medicine. According to data from OpenAlex, Colin G. Miller has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 10 papers in Surgery and 10 papers in Orthopedics and Sports Medicine. Recurrent topics in Colin G. Miller's work include Osteoarthritis Treatment and Mechanisms (8 papers), Bone health and osteoporosis research (7 papers) and Bone Metabolism and Diseases (5 papers). Colin G. Miller is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (8 papers), Bone health and osteoporosis research (7 papers) and Bone Metabolism and Diseases (5 papers). Colin G. Miller collaborates with scholars based in United States, Germany and France. Colin G. Miller's co-authors include Ali Guermazi, Frank W. Roemer, Curtis W. Hayes, Garry E. Gold, F. Eckstein, M.D. Crema, J. Duryea, Johanne Martel‐Pelletier, Flavia Cicuttini and David J. Hunter and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Spine.

In The Last Decade

Colin G. Miller

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin G. Miller United States 17 469 334 233 198 176 38 1.1k
Olga Kubassova United Kingdom 21 627 1.3× 201 0.6× 265 1.1× 97 0.5× 87 0.5× 55 987
Christian S. Thudium Denmark 21 694 1.5× 176 0.5× 121 0.5× 379 1.9× 72 0.4× 80 1.2k
W.E. van Spil Netherlands 20 1.2k 2.6× 416 1.2× 148 0.6× 219 1.1× 152 0.9× 41 1.5k
Asger Reinstrup Bihlet Denmark 18 893 1.9× 341 1.0× 126 0.5× 280 1.4× 101 0.6× 81 1.4k
Aare Märtson Estonia 21 424 0.9× 329 1.0× 97 0.4× 382 1.9× 64 0.4× 74 1.2k
J.R. Andersen Denmark 16 804 1.7× 332 1.0× 137 0.6× 242 1.2× 90 0.5× 57 1.3k
Marieke E. Vianen Netherlands 19 530 1.1× 340 1.0× 72 0.3× 152 0.8× 32 0.2× 23 1.4k
Jun Yuan China 18 215 0.5× 143 0.4× 77 0.3× 298 1.5× 34 0.2× 52 1.2k
Seong Jae Choi South Korea 19 543 1.2× 91 0.3× 100 0.4× 275 1.4× 23 0.1× 33 1.2k

Countries citing papers authored by Colin G. Miller

Since Specialization
Citations

This map shows the geographic impact of Colin G. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin G. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin G. Miller more than expected).

Fields of papers citing papers by Colin G. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin G. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin G. Miller. The network helps show where Colin G. Miller may publish in the future.

Co-authorship network of co-authors of Colin G. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Colin G. Miller. A scholar is included among the top collaborators of Colin G. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin G. Miller. Colin G. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Virgolini, Irene, Shadfar Bahri, Andreas Kjær, et al.. (2021). A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for 68Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors. Journal of Nuclear Medicine. 63(3). 376–383. 5 indexed citations
3.
Raunig, David, Annette M. Schmid, Colin G. Miller, et al.. (2021). Radiologists and Clinical Trials: Part 2: Practical Statistical Methods for Understanding and Monitoring Independent Reader Performance. Therapeutic Innovation & Regulatory Science. 55(6). 1122–1138. 6 indexed citations
4.
Roemer, Frank W., Colin G. Miller, Christine R. West, et al.. (2017). Development of an imaging mitigation strategy for patient enrolment in the tanezumab nerve growth factor inhibitor (NGF-ab) program with a focus on eligibility assessment. Seminars in Arthritis and Rheumatism. 47(3). 323–330. 12 indexed citations
5.
Miller, Colin G., Antonio Nino, Allison R. Northcutt, et al.. (2016). Evaluation of Quantitative Computed Tomography Cortical Hip Quadrant in a Clinical Trial With Rosiglitazone: A Potential New Study Endpoint. Journal of Clinical Densitometry. 19(4). 485–491. 7 indexed citations
6.
Gold, Garry E., Flavia Cicuttini, M.D. Crema, et al.. (2015). OARSI Clinical Trials Recommendations: Hip imaging in clinical trials in osteoarthritis. Osteoarthritis and Cartilage. 23(5). 716–731. 132 indexed citations
7.
Hunter, David J., Nigel Arden, Flavia Cicuttini, et al.. (2015). OARSI Clinical Trials Recommendations: Hand imaging in clinical trials in osteoarthritis. Osteoarthritis and Cartilage. 23(5). 732–746. 21 indexed citations
8.
Hunter, David J., Roy D. Altman, Flavia Cicuttini, et al.. (2015). OARSI Clinical Trials Recommendations: Knee imaging in clinical trials in osteoarthritis. Osteoarthritis and Cartilage. 23(5). 698–715. 113 indexed citations
9.
Krueger, Diane, et al.. (2015). A DXA Whole Body Composition Cross-Calibration Experience: Evaluation With Humans, Spine, and Whole Body Phantoms. Journal of Clinical Densitometry. 19(2). 220–225. 12 indexed citations
10.
Roemer, Frank W., Curtis W. Hayes, Colin G. Miller, Kevin B. Hoover, & Ali Guermazi. (2014). Imaging atlas for eligibility and on-study safety of potential knee adverse events in anti-NGF studies (Part 1). Osteoarthritis and Cartilage. 23. S22–S42. 28 indexed citations
11.
Yan, Zhennan, Shaoting Zhang, Boubakeur Belaroussi, et al.. (2014). An Automated and Robust Framework for Quantification of Muscle and Fat in the Thigh. 3173–3178. 7 indexed citations
12.
Miller, Colin G., Ali Guermazi, & Frank W. Roemer. (2014). The current status of imaging in anti-NGF clinical trials. Osteoarthritis and Cartilage. 23. S3–S7. 19 indexed citations
13.
Yan, Zhennan, Shaoting Zhang, Boubakeur Belaroussi, et al.. (2014). Atlas-based liver segmentation and hepatic fat-fraction assessment for clinical trials. Computerized Medical Imaging and Graphics. 41. 80–92. 20 indexed citations
14.
Navarro‐Compán, Victoria, et al.. (2013). Measurement error in the assessment of radiographic progression in rheumatoid arthritis (RA) clinical trials: the smallest detectable change (SDC) revisited. Annals of the Rheumatic Diseases. 73(6). 1067–1070. 14 indexed citations
15.
Graverand, Marie‐Pierre Hellio Le, et al.. (2013). Considerations when designing a disease-modifying osteoarthritis drug (DMOAD) trial using radiography. Seminars in Arthritis and Rheumatism. 43(1). 1–8. 16 indexed citations
16.
Brunell, Robert, Curtis W. Hayes, K D Brandt, et al.. (2012). A 2-year randomized, double-blind, placebo-controlled, multicenter study of an oral selective iNOS inhibitor in subjects with symptomatic osteoarthritis of the knee. Osteoarthritis and Cartilage. 20. S38–S38. 5 indexed citations
17.
Graverand, Marie‐Pierre Hellio Le, Robert Brunell, Curtis W. Hayes, et al.. (2012). A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Annals of the Rheumatic Diseases. 72(2). 187–195. 105 indexed citations
18.
Fitzpatrick, Lorraine A., John P. Bilezikian, Gitanjali Paul, et al.. (2011). Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristics. PubMed. 1(1). 11–19. 5 indexed citations
19.
Brett, Alan, Colin G. Miller, Curtis W. Hayes, et al.. (2009). Development of a Clinical Workflow Tool to Enhance the Detection of Vertebral Fractures. Spine. 34(22). 2437–2443. 33 indexed citations
20.
Milner, Paul, et al.. (1970). Hemoglobin O Arab in Four Negro Families and Its Interaction with Hemoglobin S and Hemoglobin C. New England Journal of Medicine. 283(26). 1417–1425. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olga Kubassova Breakdown of academic impact, for papers by Christian S. Thudium Breakdown of academic impact, for papers by W.E. van Spil Breakdown of academic impact, for papers by Asger Reinstrup Bihlet Breakdown of academic impact, for papers by Aare Märtson Breakdown of academic impact, for papers by J.R. Andersen Breakdown of academic impact, for papers by Marieke E. Vianen Breakdown of academic impact, for papers by Jun Yuan Breakdown of academic impact, for papers by Seong Jae Choi
Rankless by CCL
2026